Correlation Between Bristol Myers and 90331HPL1

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and 90331HPL1 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and 90331HPL1 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and US BANK NATIONAL, you can compare the effects of market volatilities on Bristol Myers and 90331HPL1 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of 90331HPL1. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and 90331HPL1.

Diversification Opportunities for Bristol Myers and 90331HPL1

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bristol and 90331HPL1 is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and US BANK NATIONAL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US BANK NATIONAL and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with 90331HPL1. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US BANK NATIONAL has no effect on the direction of Bristol Myers i.e., Bristol Myers and 90331HPL1 go up and down completely randomly.

Pair Corralation between Bristol Myers and 90331HPL1

Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 1.25 times more return on investment than 90331HPL1. However, Bristol Myers is 1.25 times more volatile than US BANK NATIONAL. It trades about -0.14 of its potential returns per unit of risk. US BANK NATIONAL is currently generating about -0.52 per unit of risk. If you would invest  5,994  in Bristol Myers Squibb on October 1, 2024 and sell it today you would lose (226.00) from holding Bristol Myers Squibb or give up 3.77% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy38.1%
ValuesDaily Returns

Bristol Myers Squibb  vs.  US BANK NATIONAL

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady primary indicators, Bristol Myers may actually be approaching a critical reversion point that can send shares even higher in January 2025.
US BANK NATIONAL 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days US BANK NATIONAL has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for US BANK NATIONAL investors.

Bristol Myers and 90331HPL1 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and 90331HPL1

The main advantage of trading using opposite Bristol Myers and 90331HPL1 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, 90331HPL1 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 90331HPL1 will offset losses from the drop in 90331HPL1's long position.
The idea behind Bristol Myers Squibb and US BANK NATIONAL pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Global Correlations
Find global opportunities by holding instruments from different markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators